Clinical Trial Update: A Monocentric Study Assessing the Efficacy of the Nitrosylated Hemoglobin as Biomarker for Detecting the Development of a Cardiovascular Complication During or After Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nitrosylated hemoglobin as a biomarker for detecting cardiovascular complications during or after surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Complications

Snippet

Sponsor: Université Catholique de Louvain | Conditions: Cardiovascular Complications | Phase 2 | Status: UNKNOWN